✦ LIBER ✦

Approaches to seizure risk assessment in preclinical drug discovery

✍ Scribed by Alison Easter; M. Elizabeth Bell; James R. Damewood Jr.; William S. Redfern; Jean-Pierre Valentin; Matthew J. Winter; Carlos Fonck; Russell A. Bialecki

Book ID: 113569012
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 345 KB
Volume: 14
Category: Article
ISSN: 1359-6446
DOI: 10.1016/j.drudis.2009.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strategy to reduce seizure liability in

Strategy to reduce seizure liability in drug discovery

✍ M. Elizabeth Bell; Russell Bialecki 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A mechanistic approach to assess the pro

A mechanistic approach to assess the proarrhythmic risk of QT-prolonging drugs in preclinical pharmacologic studies

✍ John C. Shryock; Yejia Song; Lin Wu; Heather Fraser; Luiz Belardinelli 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Novel Approaches to Drug Discovery in Si

Novel Approaches to Drug Discovery in Signal Transduction

📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB

Toxicogenomics in drug discovery: from p

Toxicogenomics in drug discovery: from preclinical studies to clinical trials

✍ Yi Yang; Eric A.G. Blomme; Jeffrey F. Waring 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 432 KB

Editorial: Novel approaches to drug disc

Editorial: Novel approaches to drug discovery in signal transduction

✍ Lodewijk Dekker 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Approaches to higher-throughput pharmaco

Approaches to higher-throughput pharmacokinetics (HTPK) in drug discovery

✍ Alan P Watt; Denise Morrison; David C Evans 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 177 KB